Osteologix to Present at Lazard Capital Markets 4th Annual Healthcare Conference
Monday November 26, 8:15 am ET
Live Webcast Scheduled November 28, 10:00 a.m. EST
SAN FRANCISCO--(BUSINESS WIRE)--Osteologix Inc. (OTC BB: OLGX.OB) today announced that Philip J. Young, president and CEO of Osteologix, will present a corporate overview Wednesday, November 28, at 10:00 a.m. EST during the Lazard Capital Markets 4th Annual Healthcare Conference at the New York Palace Hotel in New York City. A live audio webcast and slide presentation will be available via the internet by visiting www.osteologix.com and clicking the link provided under 'Latest News'. An archived presentation will be available for 90 days.
About Osteologix
Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of musculoskeletal diseases. The Company's vision is to improve the health of those afflicted with musculoskeletal diseases such as osteoporosis. Its lead product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.
For Further Information, Contact:
RedChip Companies, Inc.
500 Winderley Place, Suite 100, Orlando, FL 32751, (800) 733-2447,
Fax: (407) 644-0758, info@redchip.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment